Minneapolis – Atirix Medical Systems, Inc. announced today that it will exhibit at AHRA’s 45th Annual Meeting and Exposition being held July 9 – 12 in Anaheim, Cal. Atirix will reveal the latest release of its flagship product, the patented QC-Track® system, and provide product demos in booth 338.

The QC-Track 5.4 release introduces new capabilities for ultrasound QC, including ACR transducer phantom QC, as well as a workflow to track the ultrasound transducer HLD needed for “semi-critical devices” used for intracavitary exams.

QC-Track 5.4 also includes enhancements to support the new FDA EQUIP process for Mammography Quality Standards Act (MQSA) compliance. Since its introduction at RSNA 2008, QC-Track has been proven annually in MQSA inspections across the country. The latest QC-Track features make the sign off process even more convenient for lead interpreting physicians.

For those attendees interested in the latest TJC requirements, Atirix will also be displaying QC-Track’s enhancements and improvements to phantom QC for CT and MRI. There are also new capabilities for advanced phantom research, including the ability to generate detailed, slice-by-slice phantom data into a data cube for analysis.

--

Atirix offers products to diagnostic imaging centers to improve productivity and ensure compliance with federal, state and local regulations. The QC-Track system is an enterprise Quality Control Information System (QCIS™) for paperless device quality control, ACR CEU/CME and exam tracking, apron tracking and PM/service tracking. Hospitals, clinics and academic imaging centers in more than 30 states, including six of the 10 largest U.S. healthcare systems, use Atirix products for day-to-day radiation safety, quality control and regulatory reporting needs. The patented QC-Track system is available in the U.S. and Canada from Atirix.

Health IT Homepage